Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124811406 | 12481140 | 6 | F | 20160604 | 20160720 | 20160620 | 20160725 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-045035 | BRISTOL MYERS SQUIBB | 67.00 | YR | F | Y | 112.40000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124811406 | 12481140 | 1 | PS | ELOTUZUMAB. | ELOTUZUMAB | 1 | Intravenous (not otherwise specified) | 1139 MG, UNK | Y | 761035 | 1139 | MG | |||||||
| 124811406 | 12481140 | 2 | SS | BORTEZOMIB | BORTEZOMIB | 1 | Unknown | 2.93 MG, UNK | U | 0 | 2.93 | MG | |||||||
| 124811406 | 12481140 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, UNK | Y | 0 | 20 | MG | |||||||
| 124811406 | 12481140 | 4 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | QD | ||||||
| 124811406 | 12481140 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | Unknown | U | 0 | ||||||||||
| 124811406 | 12481140 | 6 | SS | EXTERNAL-METOPROLOL SUCCINATE | METOPROLOL SUCCINATE | 1 | Unknown | U | 0 | ||||||||||
| 124811406 | 12481140 | 7 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 124811406 | 12481140 | 8 | SS | EXTERNAL-CHLORTHALIDONE | CHLORTHALIDONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124811406 | 12481140 | 1 | Plasma cell myeloma |
| 124811406 | 12481140 | 2 | Plasma cell myeloma |
| 124811406 | 12481140 | 3 | Plasma cell myeloma |
| 124811406 | 12481140 | 4 | Plasma cell myeloma |
| 124811406 | 12481140 | 5 | Product used for unknown indication |
| 124811406 | 12481140 | 6 | Product used for unknown indication |
| 124811406 | 12481140 | 7 | Product used for unknown indication |
| 124811406 | 12481140 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124811406 | 12481140 | OT |
| 124811406 | 12481140 | LT |
| 124811406 | 12481140 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124811406 | 12481140 | Anaemia | |
| 124811406 | 12481140 | Back pain | |
| 124811406 | 12481140 | Fractured sacrum | |
| 124811406 | 12481140 | Hypotension | |
| 124811406 | 12481140 | Lymphocyte count decreased | |
| 124811406 | 12481140 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124811406 | 12481140 | 1 | 20160531 | 0 | ||
| 124811406 | 12481140 | 2 | 20160531 | 0 | ||
| 124811406 | 12481140 | 3 | 20160531 | 0 | ||
| 124811406 | 12481140 | 4 | 20160531 | 0 |